Nanjing Competitors

688273 Stock

30.50 3.29 12.09%

Nanjing Medlander Medical competes with Agricultural Bank, Anhui Xinhua, Gifore Agricultural, Shanghai Yaoji, and Hongrun Construction; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Nanjing Medlander competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Nanjing Medlander to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Nanjing Medlander Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Nanjing Medlander competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
27.80	30.50	33.20

Details

Intrinsic

Valuation

Low	Real	High
19.26	21.96	33.55

Details

Naive

Forecast

Low	Next	High
29.56	32.26	34.95

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
20.87	24.88	28.89

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nanjing Medlander. Your research has to be compared to or analyzed against Nanjing Medlander's peers to derive any actionable benefits. When done correctly, Nanjing Medlander's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Nanjing Medlander Medical.

Nanjing Medlander Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Nanjing Medlander and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Nanjing and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Nanjing Medlander Medical does not affect the price movement of the other competitor.

	601288	601801	300022	002605	002062	301052	601929	002905
601288		0.22	0.14	-0.27	0.22	0.0	-0.16	-0.21	601288
601801	0.22		0.02	0.59	0.05	0.66	0.61	0.46	601801
300022	0.14	0.02		0.07	0.33	0.53	0.37	0.0	300022
002605	-0.27	0.59	0.07		-0.3	0.76	0.83	0.71	002605
002062	0.22	0.05	0.33	-0.3		0.1	-0.21	-0.46	002062
301052	0.0	0.66	0.53	0.76	0.1		0.81	0.5	301052
601929	-0.16	0.61	0.37	0.83	-0.21	0.81		0.69	601929
002905	-0.21	0.46	0.0	0.71	-0.46	0.5	0.69		002905
	601288	601801	300022	002605	002062	301052	601929	002905

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

601929	+ 0.83	002605
601929	+ 0.81	301052
301052	+ 0.76	002605
002905	+ 0.71	002605
002905	+ 0.69	601929
301052	+ 0.66	601801

High negative correlations

002905	- 0.46	002062
002062	- 0.3	002605
002605	- 0.27	601288
601929	- 0.21	002062
002905	- 0.21	601288
601929	- 0.16	601288

Risk-Adjusted Indicators

There is a big difference between Nanjing Stock performing well and Nanjing Medlander Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nanjing Medlander's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
601288	0.90	0.07	0.12	0.39	1.19	(0.99)	2.20	(1.60)	7.85
601801	1.70	(0.03)	0.05	(0.02)	2.08	(1.88)	2.75	(3.70)	11.06
300022	2.95	0.54	0.21	(3.14)	2.70	(3.89)	8.33	(5.63)	15.20
002605	2.56	0.08	0.04	0.09	3.26	(2.60)	5.50	(5.06)	16.47
002062	1.74	0.16	0.14	(7.76)	1.79	(2.15)	4.20	(3.51)	13.65
301052	2.83	0.18	0.08	(3.65)	3.63	(3.02)	7.51	(5.87)	15.37
601929	3.25	0.13	0.07	(0.45)	3.99	(3.76)	9.83	(7.22)	20.14
002905	2.92	0.33	0.09	1.04	3.83	(2.96)	10.00	(7.39)	20.00

Cross Equities Net Income Analysis

Compare Nanjing Medlander Medical and related stocks such as Agricultural Bank, Anhui Xinhua Media, and Gifore Agricultural Net Income Over Time

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
601288	94.9 B	121.9 B	145.1 B	166.3 B	179.5 B	180.6 B	183.9 B	193 B	202.8 B	212.1 B	215.9 B	241.2 B	259.1 B	269.4 B	309.8 B	209.4 B
601801	156.4 M	396.6 M	498.8 M	605.7 M	694.2 M	772.8 M	1.1 B	1.1 B	1.1 B	557 M	615.7 M	639.7 M	707.8 M	935.8 M	1.1 B	666.4 M
300022	941 K	70.4 M	12.8 M	12.7 M	12.7 M	12.7 M	11.8 M	(44.7 M)	10.5 M	(142.9 M)	(16.2 M)	15.3 M	11.1 M	16.8 M	15.1 M	15.9 M
002605	39.3 M	72.5 M	95.8 M	117 M	122.3 M	95 M	97.5 M	76.8 M	129.7 M	344.8 M	1.1 B	573.7 M	348.6 M	562.5 M	646.8 M	679.2 M
002062	40.7 M	141.6 M	132.1 M	179.2 M	204.5 M	211.1 M	233 M	272 M	300.4 M	350.8 M	414 M	399.7 M	364.4 M	339.1 M	389.9 M	249.8 M
301052	51.9 M	51.9 M	51.9 M	51.9 M	51.9 M	51.9 M	51.9 M	51.9 M	51.9 M	51.9 M	40.9 M	56.7 M	40.8 M	53.6 M	61.7 M	53.7 M
601929	28.6 M	363.9 M	383.5 M	402.1 M	409.8 M	411.3 M	366 M	375.4 M	304.5 M	100.4 M	64.8 M	26.6 M	(424.6 M)	(692.9 M)	(623.7 M)	(592.5 M)
002905	195.5 M	195.5 M	195.5 M	195.5 M	195.5 M	195.5 M	195.5 M	211.5 M	158 M	106.6 M	(506 M)	(355.9 M)	(381.3 M)	13.3 M	12 M	12.6 M

Nanjing Medlander Medical and related stocks such as Agricultural Bank, Anhui Xinhua Media, and Gifore Agricultural Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Nanjing Medlander Medical financial statement analysis. It represents the amount of money remaining after all of Nanjing Medlander Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Nanjing Medlander Competitive Analysis

The better you understand Nanjing Medlander competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Nanjing Medlander's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Nanjing Medlander's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	688273	601288	601801	300022	002605	002062	301052	601929	002905
	12.09 30.50 Nanjing	0.20 5.09 Agricultural	1.60 6.99 Anhui	0.43 6.88 Gifore	8.27 29.08 Shanghai	0.99 5.00 Hongrun	6.27 30.53 GUOMAI	0.95 2.12 JiShi	10.06 9.85 Guangzhou
Market Volatility (90 Days Market Risk)	Not too volatile	Not too volatile	Somewhat reliable	Moderately volatile	Not too volatile	Slightly risky	Not too volatile	Dangerous	Slightly risky
Market Performance (90 Days Performance)	OK	Very Weak	Very Weak	Modest	Very Weak	Weak	Very Weak	Very Weak	Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Very Small	Low	Low	Low	Very Small	Low	Very Small	Low	Quite High
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Strong Hold	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Strong Sell
Net Asset	1.53 B	39.87 T	18.86 B	1.84 B	4.72 B	15.6 B	805.24 M	14.44 B	4.04 B
Profit Margin	0.24	0.49	0.078	-0.0047	0.12	0.052	0.0668	-0.23	-0.17
EBITDA	124.57 M	N/A	722.41 M	67.26 M	679.98 M	587.34 M	44.42 M	494.15 M	(108.78 M)
Operating Margin	0.11	0.58	0.0627	-0.0188	0.23	0.0577	0.19	-0.15	-0.13
Current Valuation	2.14 B	413.04 B	4.91 B	3.21 B	11.94 B	6.37 B	2.72 B	12.19 B	6.1 B
Price To Book	2.33	0.61	1.18	6.24	3.57	1.4	4.34	1.33	77.12
Retained Earnings	244.7 M	1.11 T	5.88 B	(496.98 M)	2.49 B	2.69 B	252.39 M	255.11 M	(940.07 M)
Beta	-0.099	0.22	0.53	0.43	0.71	0.27	1.53	0.45	0.51
Number Of Employees	N/A	451 K	6.35 K	1.16 K	1.73 K	1.82 K	N/A	6.01 K	N/A
Shares Outstanding	100 M	319.24 B	1.96 B	494.24 M	414.77 M	1.24 B	98.96 M	3.49 B	376.32 M
Cash Flow From Operations	136.91 M	1.83 T	789.51 M	64.86 M	450.27 M	1.01 B	77.46 M	450.11 M	458.23 M
Annual Yield	0.0328	N/A	N/A	N/A	0.0309	0.02	0.0032	N/A	N/A
Total Debt	6.13 M	36.98 T	1.41 B	249.99 M	399.14 M	2.51 B	134.02 M	257.41 M	3.24 B
Return On Equity	0.0751	0.0951	0.0652	0.0313	0.14	0.0906	0.0519	-0.079	-1.26
Return On Asset	0.0386	0.0067	0.0237	0.0164	0.0818	0.0197	0.0324	-0.0137	-0.0296
Book Value Per Share	13.38	7.27	5.93	1.1	8.25	4.07	7.03	1.58	0.13
Total Asset	1.53 B	39.87 T	18.86 B	1.84 B	4.72 B	15.6 B	805.24 M	14.44 B	4.04 B
Target Price	N/A	5.02	8.4	14.5	33.59	18.0	N/A	N/A	5.8
Last Dividend Paid	N/A	0.23	0.31	N/A	0.9	0.1	0.073	N/A	N/A
Shares Owned By Institutions	6.68	9.05	4.75	0.27	9.92	0.71	2.95	0.2	0.41
Market Capitalization	3.05 B	1.77 T	13.69 B	3.4 B	12.06 B	6.19 B	3.02 B	7.4 B	3.71 B
Price To Earnings To Growth	N/A	2.04	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Price To Sales	7.22	3.13	1.4	1.24	3.42	1.0	5.76	3.73	3.49
Net Income	89.82 M	269.36 B	935.82 M	16.8 M	562.46 M	339.06 M	53.64 M	(692.95 M)	13.35 M
Earnings Per Share	1.03	0.73	0.39	-0.02	1.01	0.3	0.21	-0.24	-0.48
Shares Owned By Insiders	70.26	84.51	78.82	46.05	47.9	53.11	38.6	38.87	75.92
Revenue	340.82 M	694.64 B	11.24 B	2.65 B	4.31 B	6.43 B	478.12 M	1.6 B	1.37 B
Working Capital	1.04 B	N/A	7.83 B	636.53 M	641.34 M	2.17 B	554.62 M	(891.65 M)	(384.9 M)
Gross Profit	422.68 M	565.3 B	2.16 B	325.99 M	1.43 B	1.06 B	251.08 M	356.62 M	129.82 M
Day Typical Price	29.37	5.1	6.95	6.9	28.38	5.01	29.91	2.11	9.85
Accumulation Distribution	0.11	0.0078	0.0242	0.0243	0.0899	0.0198	0.0732	0.0327	N/A
Market Facilitation Index	3.4	0.04	0.17	0.17	2.64	0.1	2.25	0.07	N/A
Daily Balance Of Power	0.9676	0.25	0.6471	(0.18)	0.8409	(0.50)	0.8	0.2857	9.2 T
Period Momentum Indicator	3.29	0.01	0.11	(0.03)	2.22	(0.05)	1.8	0.02	0.9
Rate Of Daily Change	1.12	1.0	1.02	1.0	1.08	0.99	1.06	1.01	1.1
Day Median Price	28.8	5.1	6.94	6.91	28.03	5.01	29.61	2.11	9.85
Price Action Indicator	3.34	(0.01)	0.11	(0.04)	2.16	(0.04)	1.83	0.025	0.45
Coefficient Of Variation	860.5	1962.21	15845.08	680.71	7205.21	1401.59	1981.01	2400.44	1377.44
Mean Deviation	1.65	0.8966	1.7	2.95	2.56	1.74	2.83	3.25	2.92
Jensen Alpha	0.3035	0.0662	(0.03)	0.5366	0.0831	0.1584	0.1772	0.1327	0.3299
Total Risk Alpha	0.6134	0.2039	0.2877	1.04	0.4661	0.4603	0.6606	0.7332	0.8312
Sortino Ratio	0.1813	0.1222	0.0511	0.2148	0.0441	0.1384	0.0761	0.0656	0.0939
Downside Variance	4.84	1.73	4.91	9.58	11.03	3.8	14.7	18.8	18.85
Standard Deviation	2.58	1.21	2.26	3.85	3.42	2.39	3.82	4.45	4.25
Kurtosis	6.62	3.43	0.8189	0.3644	0.8681	3.4	0.5133	0.6814	1.19
Potential Upside	4.46	2.2	2.75	8.33	5.5	4.2	7.51	9.83	10.0
Treynor Ratio	2.35	0.3943	(0.02)	(3.14)	0.0897	(7.76)	(3.65)	(0.45)	1.04
Maximum Drawdown	10.01	7.85	11.06	15.2	16.47	13.65	15.37	20.14	20.0
Variance	6.67	1.47	5.12	14.84	11.71	5.72	14.56	19.83	18.08
Market Risk Adjusted Performance	2.36	0.4043	(0.01)	(3.13)	0.0997	(7.75)	(3.64)	(0.44)	1.05
Risk Adjusted Performance	0.1078	0.0472	0.0116	0.1356	0.0195	0.0685	0.0517	0.0443	0.0712
Skewness	1.59	(0.65)	0.4101	0.4749	0.2964	1.15	(0.01)	0.2026	0.1519
Semi Deviation	1.87	1.19	2.08	2.7	3.26	1.79	3.63	3.99	3.83
Information Ratio	0.1546	0.1326	0.0501	0.1726	0.0428	0.1128	0.0764	0.0639	0.0959
Value At Risk	(3.15)	(1.60)	(3.70)	(5.63)	(5.06)	(3.51)	(5.87)	(7.22)	(7.39)
Expected Short fall	(1.71)	(0.99)	(1.88)	(3.89)	(2.60)	(2.15)	(3.02)	(3.76)	(2.96)
Downside Deviation	2.2	1.32	2.22	3.1	3.32	1.95	3.83	4.34	4.34
Semi Variance	3.51	1.41	4.34	7.29	10.63	3.2	13.17	15.92	14.66

Nanjing Medlander Competition Performance Charts

Five steps to successful analysis of Nanjing Medlander Competition

Nanjing Medlander's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Nanjing Medlander Medical in relation to its competition. Nanjing Medlander's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Nanjing Medlander in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Nanjing Medlander's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Nanjing Medlander Medical, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Nanjing Medlander position

In addition to having Nanjing Medlander in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Precious Metals Thematic Idea Now

Precious Metals

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Precious Metals theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Nanjing Stock

Nanjing Medlander financial ratios help investors to determine whether Nanjing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanjing with respect to the benefits of owning Nanjing Medlander security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nanjing Competitors

Specify up to 10 symbols:

Nanjing Medlander Competition Correlation Matrix

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Nanjing Medlander Medical and related stocks such as Agricultural Bank, Anhui Xinhua Media, and Gifore Agricultural Net Income description

Nanjing Medlander Competitive Analysis

Nanjing Medlander Competition Performance Charts

Five steps to successful analysis of Nanjing Medlander Competition

Complement your Nanjing Medlander position

Did You Try This Idea?

Run Precious Metals Thematic Idea Now

Precious Metals

Other Information on Investing in Nanjing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY